pretty peeved that their contribution hasn't been recognized

Despite the fact that the erectile dysfunction medications Cialis has been on the market for years, some of the scientists involved in its development are still pretty peeved that their contribution hasn't been recognized.

In the legal action Vanderbilt University vs. ICOS Corporation, three Vanderbilt scientists namely Dr. Jackie Corbin, Dr. Sharron Francis and Dr. Sekhar Konjeti claim that their names have not been added to the patent held by ICOS for Cialis. These scientists say they worked with Glaxo before the research went to ICOS providing a lot of vital clinical information and said that they should be listed as co inventors.

Vanderbilt Medical Center has unfortunately reached the end of the road because the Supreme Court appeal has been rejected. The scientists said that despite the fact that they had discovered loads of information about the enzyme phosphodiesterase-5 and that they believed it could be effective to treat erectile dysfunction the legal establishment didn't think their claim was good enough to merit recognition.

The legal team of ICOS however said that the information provided by the three scientists from Vanderbilt was not an intrinsic part of the final pharmaceutical development of Cialis.

The Vanderbilt scientists say that it's now over and that they can't pursue any more legal remedies and therefore they will just have to content themselves with the knowledge that the fact that millions of men are able to get erections around the world had something to do with them despite the fact that they are not appreciated for what they did morally or financially.

Cialis, unlike the other two impotence remedies Viagra and Levitra works for much longer and therefore is extremely popular especially in its new form Cialis Daily. Men using this new version of Cialis only have to take a small tablet every morning to have better erectile function 24/7. The drug Cialis is the second best selling erectile dysfunction remedy worldwide and could one day overtake Viagra.